文献速递脊柱关节炎

JAK-STAT信号在脊柱关节炎发病机制中的作用及JAK抑制的角色综述

A review of JAK-STAT signalling in the pathogenesis of spondyloarthritis and the role of JAK inhibition.
PubMed 文献 · Rheumatology (Oxford) · 2022-01-01

本文综述JAK-STAT信号通路在脊柱关节炎(SpA)发病机制中的作用,并总结JAK抑制剂在SpA临床试验中的安全性和有效性。多种SpA相关细胞因子通过JAK-STAT通路信号传导,口服小分子JAK抑制剂可抑制这些致病信号。

要点

  • 多种SpA相关细胞因子通过JAK-STAT通路直接或间接信号传导。
  • JAK信号调控固有和适应性免疫细胞的发育与成熟。
  • JAK抑制剂可抑制SpA发病相关信号,临床试验支持其安全有效性。

核心结论

  • JAK-STAT通路在SpA发病机制中起重要作用,JAK抑制可抑制SpA相关致病信号。

研究设计与样本

  • 综述,讨论JAK信号在SpA发病机制中的作用,并参考相关SpA临床试验总结JAK抑制剂的安全性和有效性。

主要发现

  • SpA相关细胞因子包括IL-23、IL-17、IL-6、I/II型干扰素和肿瘤坏死因子,直接或间接通过JAK-STAT通路信号传导。
  • JAK信号调控固有和适应性免疫系统细胞的发育与成熟。

临床怎么用

  • 口服小分子JAK抑制剂可抑制SpA发病相关信号通路,临床试验证据支持其在SpA中的应用。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Spondyloarthritis (SpA) comprises a group of chronic inflammatory diseases with overlapping clinical, genetic and pathophysiological features including back pain, peripheral arthritis, psoriasis, enthesitis and dactylitis. Several cytokines are involved in the pathogenesis of SpA, variously contributing to each clinical manifestation. Many SpA-associated cytokines, including IL-23, IL-17, IL-6, type I/II interferon and tumour necrosis factor signal directly or indirectly via the Janus kinase (JAK)-signal transducer and activator of transcription pathway. JAK signalling also regulates development and maturation of cells of the innate and adaptive immune systems. Accordingly, disruption of this signalling pathway by small molecule oral JAK inhibitors can inhibit signalling implicated in SpA pathogenesis. Herein we discuss the role of JAK signalling in the pathogenesis of SpA and summarize the safety and efficacy of JAK inhibition by reference to relevant SpA clinical trials.

来源:Rheumatology (Oxford),查看原文。版权归原作者所有。

引用

  1. McInnes IB, Szekanecz Z, McGonagle D, et al. A review of JAK-STAT signalling in the pathogenesis of spondyloarthritis and the role of JAK inhibition. Rheumatology (Oxford). 2022. PMID: 34668515. doi:10.1093/rheumatology/keab740

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。